Chapter 28: Pharmacological Treatment of Gastrointestinal Disorders

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to another session of the Deep Dive.

Today we are strapping in for a very specific and I'd say high stakes mission.

Oh, definitely.

We have got Brenner and Stevens Pharmacology sixth edition open on the table, specifically chapter 28.

A classic text and a massive chapter I should add.

It's a beast.

It really is.

And we're approaching this with a very particular vibe today.

We're calling this our Last Minute Lecture style.

I know that feeling.

You know the feeling I'm talking about, right?

It's two in the morning, the exam is in six hours, the coffee pot is, you know, burning a hole in the carafe.

And you just need to download the entire pharmacological treatment of gastrointestinal disorders into your brain right now.

I know that feeling intimately and frankly, this is the perfect topic for that kind of urgency.

You think so?

Oh, absolutely.

Because GI complaints aren't just, you know, fodder for exams.

They are consistently one of the top reasons humans actually walk into a doctor's office.

That's a great point.

Heartburn, ulcers, nausea, constipation.

I mean, this is the bread and butter of daily medical practice.

Exactly.

So our mission is to decode this chapter, not just to pass the desk, but so we don't, you know, accidentally hurt someone next year when we're on the wards.

Right.

It's about building that foundational knowledge.

We're going to look at the acid battlefield of peptic ulcer disease.

Okay.

We'll wade through the inflammation of IBD.

We'll manage the traffic control of motility disorders.

Things moving too fast or too slow.

Right.

Exactly.

And finally, we'll handle the urge to purge.

Also known as nausea and vomiting.

The very same.

It's essentially a road trip from the esophagus all the way down to the rectum.

Which sounds lovely.

Let's start at the top then.

The stomach.

Peptic ulcer disease or PUD.

The text defines this as inflamed excavations in the mucosa.

Excavations is such a visceral word, isn't it?

It really paints a picture.

It does.

It's not subtle.

No, we aren't just talking about a little surface redness here.

We are talking about a pothole, a literal erosion where the protective lining has failed and the tissue underneath is, well, it's being eaten away.

And what's doing the eating is what surprises people, I think.

Yeah.

For decades, the medical consensus was stress.

Right.

The executive ulcer.

You have a high pressure job.

You get an ulcer,

drink some milk, try to calm down.

And we know now that's mostly wrong.

The text highlights that this is fundamentally a math problem, an imbalance.

An imbalance between what?

On one side of the equation, you have your protective factors,

mucus, bicarbonate, blood flow to the tissue.

And on the other side, you have the aggressive factors.

Yeah.

Gastric acid and pepsin.

So when the aggression outweighs the protection.

You get an excavation.

You get an ulcer.

And the text points the finger at two very specific accomplices that tip that scale.

First, NSAIDs, your ibuprofen and naproxen, and then the big one, helicobacter pylori.

H.

pylori, the bacterial villain of the piece.

I was looking at the stats and the source material and they are just staggering.

It says by age 45, nearly 20 % of people are harboring H.

pylori.

It is incredibly common.

The text mentions it increases from under 5 % at birth to about that 20 % figure by age 45.

But, and this is the nuance the text insists on.

Go on.

Most of those people are asymptomatic.

They're just walking around fine.

No idea they even have it.

Okay.

So having the bug doesn't mean you get an ulcer.

Not necessarily.

But if you flip it around and look at patients who actually have a duodenal ulcer.

What's the number then?

H.

pylori is present in almost 100 % of them.

For gastric ulcers, it's a little lower, and still around 80%.

So it's not that everyone with the bug gets an ulcer, but basically everyone with an ulcer has the bug.

Precisely.

And that insight changed everything about how we treat this.

We used to just treat the acid.

Now we know we have to treat the infection.

But, and this is a big, but you're saying you can't cure the ulcer if the stomach is still full of acid.

Exactly.

You have to stop the burn to let the tissue heal.

You have to create the right environment.

Which brings us to the machinery.

To stop the acid, you have to know how it's made.

And for that, we need to visualize the parietal cell.

The acid factory.

If you're looking at figure 28 .1 in the text, you see this parietal cell.

And on the membrane facing the stomach interior, the lumen, there's a pump.

The H plus 5K plus ATPase.

That's the one.

This is the proton pump.

This is the moneymaker.

This pump is an enzyme that physically grabs hydrogen ions, which are protons, from inside the cell and shoves them out into the stomach, while at the same time pulling potassium ions in.

So it's an exchange.

It's an exchange.

And it's moving acid against a massive concentration gradient.

The stomach is millions of times more acidic than the blood.

That takes a huge amount of energy.

So if this pump is the final door that acid walks through to get into the stomach, the pharmacological strategy becomes pretty obvious.

Lock the door.

Lock the door.

Or.

Or intercept the messengers who are telling the door to open in the first place.

Because the pump doesn't just run 24 -7 on its own, it waits for orders.

And the text lists three distinct generals giving the order to fire.

Yes, three main stimulants.

Let's name them.

We've got gastrin, acetylcholine, and histamine.

Correct.

Gastrin comes from G cells, which are in the antrum of the stomach.

So it's a hormonal signal.

Acetylcholine comes from the vagus nerve.

That's your brain -gut connection.

You smell a delicious pizza, the vagus nerve fires.

Acetylcholine hits the cell, and acid production starts.

And histamine, I always associate that with hay fever and sneezing.

It's the same molecule, just in a different location, doing a different job.

In the stomach, gastrin and acetylcholine actually stimulate these nearby cells called enterochromophen -like cells, or ECL cells.

And the ECL cells release the histamine.

Exactly.

The histamine then floats over to the parietal cell and hits a very specific receptor, the H2 receptor.

Not H1, which is for allergies, but H2.

And hitting that receptor triggers a chain reaction inside the cell.

The text mentions KMP here.

Right.

Histamine binds to the H2 receptor, which activates an enzyme called adenylate cyclase.

That enzyme increases the amount of KMP, cyclic adenosine monophosphate, inside the cell.

And that CMP is the final internal signal that says, turn on the proton pump.

Go.

Okay.

So we have our map.

We can either attack the H2 receptor to block the message, or we can attack the pump itself.

The two major strategies.

This creates our two major drug classes.

Let's start with the H2 blockers.

The histamine H2 receptor antagonists.

The text lists four key players here.

Simetidine, famotidine, ranitidine, and nizatidine.

How exactly do these work?

Is it just like putting up a wall in front of the receptor?

It's competitive inhibition.

It's a bit more elegant than a wall.

If you look at figure 28 .2 in the text, it actually shows the chemical structures.

These drugs look structurally very similar to histamine.

So they fit perfectly into the H2 receptor on the parietal cell and just park there.

They steal the parking spot.

Precisely.

They steal the parking spot and that blocks the real histamine from getting in and starting the engine.

And by stealing the spot, they prevent that whole cascade that rise in KMP.

Exactly.

The pump doesn't get the signal, so it doesn't pump.

The text notes that these drugs reduce both the volume of acid being produced and the actual concentration of H plus ions.

And because pepsin, the digestive enzyme, needs an acidic environment to become active.

They reduce pepsin activity too.

It's a domino effect.

Clinically, what are we using these for?

What are the main indications?

They're great for dyspepsia, which is the medical term for heartburn or indigestion, GERD, and of course, peptic ulcer disease.

Okay.

The text also points out that they are especially good at inhibiting basal acid secretion, the acid your stomach makes overnight, and also meal -stimulated secretion.

What about the pharmacokinetics?

How long do they last?

It's interesting.

They have a pretty short half -life, maybe two to three hours.

But because of how they bind and the effect they have, their clinical action lasts much longer.

This allows for just once or twice daily dosing, which is great for patients.

Now, we need to pause here for a major safety alert.

Usually, these drugs are well -tolerated, right?

Very well -tolerated for the most part.

But there is one drug in this class that has a giant flashing neon warning sign next to it in the text,

cimetidine.

Yes.

Cimetidine, this is a high -yield point.

If you were taking a pharmacology exam or if you're treating a complex patient with multiple medications, you have to know this.

Why?

What does it do?

Cimetidine is a notorious inhibitor of the cytochrome P450 enzyme system in the liver.

Specifically, it says CYP2C9, CYP2D6, and CYP3A4.

That sounds like alphabet soup, but let's unpack why it matters so much.

It matters because those enzymes are the liver's garbage disposal system for dozens of other drugs.

They break them down and clear them from the body.

So if cimetidine shuts them down...

Those other drugs build up in your blood to potentially toxic levels.

The text lists some classic examples like warfarin, phenytoin, and theophylline.

Okay, so let's walk through that.

If I'm on warfarin, a blood thinner to prevent clots, and I start taking cimetidine for my heartburn...

Your warfarin levels could spike.

Your blood could become too thin and you could have the serious bleeds.

A very dangerous interaction.

And the text mentioned a strange hormonal side effect for men too.

Yes, this is another reason cimetidine has fallen out of favor.

It has weak antiandrogenic activity.

Meaning it blocks testosterone effects.

A little bit, yeah.

And in elderly men, specifically, it can cause gynecomastia, the growth of breast tissue, and even galacturia, which is milk production.

Wow.

The newer drugs like fomotidate don't really have these issues, which is why they're much more commonly used today.

Okay, so H2 blockers are a solid first line of defense, but sometimes you need the heavy artillery.

Enter the proton pump inhibitors, or PPIs.

These are the drugs that all end in aprizole.

S.

omperzole, lensoprizole, omperzole, pantroprizole.

How are these fundamentally different from the H2 blockers?

The mechanism is totally different.

H2 blockers, as we said, act on the messenger.

PPIs go straight to the machine.

They inhibit the H plus K plus ATPase proton pump directly.

They shut down the factory.

The text calls them prodrugs.

That means they aren't actually active when you swallow the pill, right?

Exactly.

And this is a really, really cool bit of pharmacology.

It's so elegant.

Explain it.

So these drugs are weak bases.

They come in an enteric -coated capsule.

So they survive the stomach acid initially.

They get absorbed from the intestine into the blood.

They circulate around the body, travel to the parietal cell, and then they diffuse into this tiny space called the secretory canalicule.

The canalicule.

That's the little canal where all the acid is actually being pumped out.

Right.

And because that space is incredibly acidic, with a pH of like one or two, the drug gets protonated.

It gains a positive charge.

And once it has a charge, it can diffuse back out.

It's trapped.

The drug accumulates there to a concentration a thousand times higher than in the blood.

And in that super acidic environment, it converts to its active metabolite.

So it uses the stomach's own acid to activate the weapon that's about to destroy the acid maker.

It's beautiful pharmacological poetic justice.

Right.

And once it's active, it forms a covalent disulfide link with the pump.

The text uses the phrase irreversible inhibition.

That sounds very final.

It is final.

A covalent bond is not a temporary interaction.

It's a strong chemical marriage.

That specific pump molecule is dead.

It will never pump another proton again.

So how does the stomach ever make acid again?

The cell has to synthesize entirely new pumps from scratch and insert them into the membrane.

Which explains the dosing right.

The drug itself has a short half -life in the blood, but the effect lasts for days.

Exactly.

Even though the drug is gone from your bloodstream in an hour or two, the pumps stay broken for 24 to 48 hours.

And that's why PPIs are so much more efficacious than H2 blockers.

How much more?

You're looking at up to 95 % inhibition of acid secretion compared to maybe 60 or 70 % with an H2 blocker.

It's a near total shutdown.

And that efficacy makes them the drug of choice for the really severe conditions like Zollinger -Ellison syndrome.

Right.

Zollinger -Ellison is a condition where you have a tumor that's just pumping out massive amounts of gastrin.

You have acid levels that are completely off the charts.

You need the complete, profound blockade that only a PPI can provide.

PPI sound like a miracle cure.

But we have to talk about the downsides.

The text lists some long -term risks that have emerged over the years.

Right.

Short -term, they are incredibly safe.

Yes.

Very well tolerated.

But when you start talking about people being on them for years.

Which many people are.

Which many people are, yes.

We start to see the physiological consequences of having virtually no stomach acid.

You can get hypomagnesemia, low magnesium levels.

There's a potential link to chronic kidney disease that's being investigated.

And what about bone health?

Yes, an increased risk of osteoporosis and fractures, particularly of the hip.

The thinking is you need an acidic environment to properly absorb dietary calcium.

And what about infections?

Well, stomach acid is your first line of defense against bacteria you swallow.

If you neutralize it, you might be more susceptible to things like pneumonia,

or importantly, clostridioids difficile C.

diff infections in the gut.

There is also a specific drug interaction alert here for omeprazole and esoprazole.

It's another one of those CYP enzyme issues.

Yes, another really important P450 interaction to know.

These two specifically inhibit an enzyme called CYP2C19.

And why does that one matter?

It matters because that is the exact enzyme needed to activate the antiplatelet drug clopidogrel.

Clopidrol, or plavix, that's given to patients, usually after they get a heart stent, to prevent blood clot.

Exactly.

And here's the kicker.

Clopidogrel is also a pro drug.

It needs CYP2C19 to turn it on.

So if a patient on clopidogrel takes omeprazole for their GERD?

The omeprazole blocks the enzyme, the clopidogrel doesn't get activated, and the patient isn't protected from having a heart attack or a stroke from a clot in their stent.

It's a huge deal.

That is a critical connection to make.

Does the text offer a workaround for a patient who needs both drugs?

It does.

It suggests that pantoprazole does not seem to have this specific interaction to the same degree, making it a safer choice in that scenario.

OK, so we have our high -tech options, H2 blockers and PPIs.

But what about the old -school stuff, antacids?

The chemistry -set approach?

These are much simpler.

They act locally right in the stomach.

They don't touch receptors or pumps.

They just chemically neutralize the acid that's already there, raising the pH.

The text focuses on two main ones, aluminum hydroxide and magnesium hydroxide, and it points out a very specific balancing act with their side effects.

It's the classic battle of the bowel movements.

A memorable phrase.

Aluminum hydroxide has a tendency to relax smooth muscle, and that causes constipation.

Magnesium hydroxide, on the other hand, is an osmotic agent that stimulates motility and causes diarrhea.

So if you take just one, you're going to be miserable in one direction or the other.

Exactly.

That's why products like Melox and Milanta combine them.

They try to cancel out each other's motility effects to achieve a neutral bowel effect.

And then there's calcium carbonate, which we all know as Tums.

It works well.

It's fast.

But the text mentions two issues.

One, like aluminum, is constipation.

The other is a phenomenon called acid rebound.

What's that?

Taking large doses of calcium can actually trigger a compensatory surge in gastrointestinal secretion, which then causes your stomach to produce even more acid later on.

Moving on from just managing the acid, let's talk about cider -protective drugs.

These aren't stopping the acid.

They're bolstering the defenses.

Right.

First up is sucrophate.

I love the description of this one.

The text calls it a viscous polymer.

It's basically a sugar molecule, sucrose, complexed with aluminum hydroxide.

And what does it do?

In an acidic environment, like the stomach, it undergoes this cross -linking process and turns into a thick, sticky paste.

It essentially turns into biological spackle.

It does.

That's a perfect analogy.

It physically adheres to the proteins in the base of the ulcer crater.

It forms a protective barrier, like a bandage, blocking acid and pepsin from eating away at the raw tissue underneath.

But because it's a sticky paste that binds to things, it can bind to other things too.

Right.

It can bind to other drugs in the stomach, like tetracycline or digoxin, and prevent their absorption.

So the cardinal rule is you have to take sucrophate at least two hours apart from any other medications.

Then we have mesoprostol.

This is a prostaglandin E1 analog.

And it's important to remember that in the stomach,

prostaglandins are the good guys.

They're cytoprotective.

Oh, so?

They stimulate mucus and bicarbonate secretion, and they also have a modest effect of suppressing acid production.

The text gives a very specific primary indication for this drug.

Yes.

Prevention of NSAID -induced ulcers.

It makes perfect sense, because NSII's work by blocking prostaglandin synthesis throughout the body.

Mesoprostol is just replacing exactly what the NSAID took away, but only in the stomach.

But there is a massive contraindication here, a huge do -not -use scenario.

Pregnancy.

Absolutely.

100 % contraindicated in pregnancy.

Why?

Prostaglandins stimulate uterine contractions.

Mesoprostol can, and is sometimes used to, induce labor or cause a miscarriage.

It's an abort efficient.

Okay.

We've suppressed the acid.

We've bandaged the wound.

But we haven't killed the villain yet.

Let's talk about treating the root cause, H.

pylori.

This is key.

The modern standard of care is that you can't just treat the acid.

You have to eradicate the bacteria.

The text is very clear on this.

What are the numbers?

It says if you just use acid inhibitors to heal an ulcer, 80 to 90 % of those ulcers will recur within a year.

Wow.

But if you kill the bug, the recurrence rate drops to under 10%.

It's basically a cure.

So what's the cocktail?

What's the treatment?

It's usually called triple or quadruple therapy.

You need a PPI to raise the pH.

Why is that part important?

Because the antibiotics work much more effectively in a less acidic environment.

So you use a PPI plus two or sometimes three antimicrobials.

The text lists the main ones as clarithromycin, amoxicillin, and metronidazole or tinidazole.

That's a pretty heavy regimen.

It is.

10 to 14 days of multiple pills, multiple times a day.

But it works.

It cures the disease.

All right.

Let's move down the track.

Section two, inflammatory bowel diseases or IBD.

First, we need to clearly distinguish the two main players, ulcerative colitis and Crohn disease.

The text makes this distinction very clear, and it's important to grasp.

Ulcerative colitis, or UC, is in a way more limited.

The inflammation is superficial, just in the mucosa.

Okay.

And it's continuous, starting in the rectum and moving proximally up the colon.

It is restricted to the colon and rectum.

And Crohn's, how is that different?

Crohn disease is transmural, meaning the information goes through the whole thickness of the gut wall, from mucosa to cirrhosa.

And it's not just in the colon.

No, it can happen anywhere in the GI tract, from the mouth to the anus.

And famously, it has skipped lesions, which means you'll have patches of severe disease right next to patches of perfectly healthy tissue.

So UC is surface level and local.

Crohn's is deep and can be widespread.

How do we treat them?

The text outlines a kind of ladder of therapies.

Right.

For an acute flare -up, when the patient is really sick, in pain, bleeding, we need to put out the fire quickly.

For that, we use glucocorticoids like hydrocortisone or bucinide.

Steroids.

Powerful anti -inflammatories.

Incredibly powerful.

They work fast to induce remission.

But the text warns they are not ideal for long -term maintenance.

Because of the side effects.

The whole host of systemic steroid side effects.

Yeah.

Bone loss, infection risk, weight gain, metabolic changes.

They're a short -term solution.

So for maintenance, for keeping the disease quiet, we switch gears.

Specifically for ulcerative colitis, the text highlights the amino salicylates.

Sulfasalazine, ulsalazine, meslamine.

These are really interesting drugs.

Sulfasalazine and ulsalazine are actually prodrugs that contain the active molecule.

5 -aminotalicylic acid or 5 -ASA.

How do they get activated?

This is another clever trick.

Bacteria that live in our colon possess an enzyme called azeroductase.

OK.

This enzyme specifically cleaves the azo bond in the prodrug, which releases the active meslamine right where it's needed most.

In the inflamed colon.

So the bacteria in your gut actually activate the drug that's meant to treat your gut inflammation.

Exactly.

It's a fantastic drug delivery system.

It allows for high concentrations of the drug locally in the colon with fewer systemic side effects.

And what does mesalamine do?

It's thought to work by inhibiting prostaglandin synthesis and scavenging free radicals, both of which reduce inflammation.

But for the more severe cases or when these don't work, the text brings in the heavy guns, the biologics, the monoclonal antibodies.

These are highly targeted therapies.

First, you have the TNF -alpha inhibitors like infliximab and delimumab.

What's TNF -alpha?

Tumor necrosis factor alpha.

It's a master cytokine, a key signaling protein that drives the whole inflammatory response.

So if you can block it, you can dampen the entire process.

And then there are the integrin antagonists like vitilizumab.

Integrin antagonists.

That sounds like science fiction, but the mechanism is just fascinating.

Integrins are adhesion proteins like molecular velcro on the surface of our white blood cells.

And what do they do?

They help the white blood cells stick to the walls of blood vessels so they can then crawl out and migrate into the tissues where the inflammation is.

So if you block the integrin.

You block the velcro.

Vitilizumab specifically blocks an integrin that is crucial for lymphocytes to migrate into GI tissue.

It basically stops the inflammatory soldiers from being able to enter the battlefield in the first place.

That is incredible precision.

Okay, let's shift gears.

We've talked about holes in the lining and inflammation.

Now let's talk about speed.

Motility disorders.

Moving things too fast or too slow.

The plumbing problems.

Let's start with GERD again, but from a motility perspective this time.

And also a condition called gastroparesis.

Gastroparesis is delayed gastric emptying.

The stomach just sits there.

It doesn't empty properly.

It's very common in long -standing diabetics because high blood sugar can damage the vagus nerve, which controls stomach contractions.

And GERD from a motility standpoint is often because the lower esophageal sphincter, the LES, is too weak or relaxes inappropriately, letting acid splash back up.

The text highlights a star player for both of these conditions.

Metaclopramide.

Metaclopramide is a prokinetic agent, meaning it promotes movement.

Its mechanism is a bit of a double whammy.

And to really understand it, you have to look at the seesaw of gut neurotransmitters.

Walk us through the seesaw.

Okay, so on one side of the seesaw, you have dopamine.

In the gut, dopamine acts as a relaxant.

It inhibits smooth muscle tone.

It's the brake pedal.

Okay, dopamine is the brake.

On the other side, you have acetylcholine.

That's the stimulant.

It causes contraction.

That's the gas pedal.

So in a condition like gastroparesis, we have either too much brake or not enough gas.

Exactly.

And metaclopramide fixes both problems.

Primarily, its main job is to block dopamine D2 receptors.

It cuts the brake lines.

But the text says it also has an effect on acetylcholine.

It does, indirectly.

By blocking presynaptic dopamine receptors, it actually removes the inhibition on acetylcholine release from the nerve endings.

So you get a surge of acetylcholine stimulating the M muscarinic receptors on the muscle.

So it takes its foot off the brake by blocking dopamine.

And at the same time, it presses the gas by increasing acetylcholine.

It's a perfect analogy.

Yeah.

The physical effect is that it tightens the lower esophageal fincher, which helps with GERD, and it increases the force of contractions in the stomach antrum, which helps with gastroparesis.

But, and this is crucial, it also relaxes the pyloric sphincter so the food can actually leave the stomach.

It sounds perfect, but I feel a butt coming.

Whenever we start messing with dopamine, there is a catch.

Because dopamine isn't just in the gut.

It's in the brain.

It's a major neurotransmitter in the brain.

And that is the major limitation of metal clopramide.

It readily crosses the blood -brain barrier.

And once it's in the brain, blocking dopamine is going to cause problems.

Significant problems.

The text warns about common things like drowsiness and fatigue, sure.

But much more concerning are the extrapyramidal effects.

Extrapyramidal.

That is one of those classic medical buzzwords.

What does it actually look like at a patient?

It looks like drug -induced Parkinson's disease.

Remember, Parkinson's is a disease caused by a lack of dopamine in the brain.

If we block dopamine with this drug, we can mimic that state.

So you see tremors.

You can see tremors, rigidity, slowed movements.

You can also see acute dystonia, which is a sustained, often very painful, muscle twisting, especially of the neck and face.

That is terrifying.

It gets worse.

With long -term use, it can cause a condition called tardive dyskinesia,

uncontrollable, repetitive movements, often of the face and tongue, like lip smacking or grimacing.

And that can be permanent, even after you stop the drug.

So this is absolutely not a take it every day for the rest of your life kind of drug.

Absolutely not.

The text emphasizes limiting its use to short -term, usually less than 12 weeks.

And there's a major contraindication.

You never use it if you suspect a GI hemorrhage or a physical obstruction.

Which makes sense.

If the pipe is physically blocked by a tumor or a twist, and you give a drug that squeezes the stomach harder, you're going to cause a perforation, a rupture.

You never, ever squeeze against a closed door.

Okay, speaking of blocked pipes,

section four, constipation.

A very, very common complaint.

The text starts with a bit of a lecture before it even gets to the drugs.

Lifestyle first.

Always the first line, fiber, fluid, and exercise.

Increasing fiber with things like psyllium or bran draws water into the stool, adds bulk, and makes it easier to pass.

But when that fails.

Then we have laxatives.

The text groups them into four main classes based on their mechanism of action.

Let's run through them.

Class one, bulk -forming agents.

This is your psyllium, your calcium polycarbophyll.

These are basically just hydrophilicolates.

You swallow them, they absorb water in the gut, they swell up, and they physically stretch the intestinal wall.

And stretching the wall is the natural trigger for the reflex to move things along.

Peristalsis is triggered by distension.

The text calls these the safest and most physiologic type of laxative.

Okay, class two, surfactants.

Or as most people know them, stool softeners.

DocuSate is the main one here.

Think of these as detergents or soaps for your stool.

They work by lowering the surface tension of the stool, which allows water and lipids or fats to mix into it.

So they don't really make you go, they just make it easier to go when you do.

Precisely.

They soften the stool.

The text notes they are great for patients who need to avoid straining -like after a major surgery, or if they have painful hemorrhoids or a hernia.

Class three, osmotic laxatives.

Magnesium oxide, laxulose, and polyethylene glycol, or PEG.

These are non -absorbable solutes.

They stay in the gut lumen, and through osmosis, they pull water from the body into the intestines.

And that water makes the stool softer and increases volume.

Right, which stimulates peristalsis.

The text has a specific side note about lactulose.

It does double duty.

Yes, very important point.

Lactulose is also a primary treatment for hepatic encephalopathy.

Which is a brain condition caused by liver failure.

Right, liver failure leads to high ammonia levels in the blood, which is toxic to the brain.

So how does a laxative help with brain ammonia?

It's quite clever.

Bacteria in the colon degrade lactulose into acidic byproducts, like lactic acid and acetic acid.

This acidifies the gut lumen.

The acid then converts ammonia, which is NH3, into the ammonium ion, NH4 plus food.

And the ammonium ion has a charge, so it can't be reabsorbed back into the blood.

Exactly.

It's trapped in the gut.

It gets pooped out.

It literally cleans the ammonia out of the blood via the stool.

There's also a safety note in this section on sodium phosphate.

A major warning.

It can cause a rare but serious and often permanent form of kidney damage called acute phosphate nephropathy.

The text says to avoid it completely in patients with known kidney disease or those on diuretics.

And finally, class four, the stimulant laxatives.

Bicicotl.

Senna.

There's the most aggressive.

They act directly on the intestinal mucosa to irritate it and stimulate the nerve plexuses within the gut wall.

They force the gut to move.

But because they're irritants, they can cause cramping.

Yes.

And the text suggests limiting them to short -term intermittent use to avoid the risk of creating a laxative -dependent bowel or causing electrolyte imbalances.

Now, there's a very specific type of constipation that gets its own section.

Opioid -induced constipation or OIC?

Opioids are notorious for this.

They hit the mu -opioid receptors in the gut and essentially paralyze it.

Right.

But we can't just stop the opioids if the patient has, say, chronic cancer pain.

What's the solution?

We use peripherally acting opioid antagonists.

The examples are methanol trexone and naloxagal.

The key word there is peripherally.

They are designed to block the opioid receptors in the gut so the bowels can start moving again.

But they are chemically structured so that they do not cross the blood -brain barrier.

So they don't get into the brain and reverse the pain relief.

Exactly.

You keep the allergies, you lose the constipation.

It's very clever pharmacology.

And what about for patients with irritable bowel syndrome with constipation or IBSC?

There are some specialized agents there, too.

Yes.

We have lupiprostone.

It's a chloride channel activator.

It opens these things called CLC2 channels on the apical membrane of the intestinal cell.

So it pumps chloride into the gut?

It does.

And where chloride goes, sodium and water follow passively.

This creates a chloride -rich fluid secretion that softens stool and increases motility.

And linoclotide?

That one's a guanylate cyclase agonist.

It works by increasing CGMP inside the cell, which has a similar end result.

More fluid secretion and increased motility.

Okay.

Let's flip the script.

We fixed the blockage.

Now, section five.

Anti -diarrheal agents.

When things are moving way too fast.

The opioids make a comeback here on the other side of the problem.

They do.

Because opioids cause constipation, they are logically excellent anti -diarrheals.

But we use very specific ones that are designed for this purpose.

Lupuramide, which is amodium, and diphenoxalate, which is inlumetil.

How do they work to stop diarrhea?

They activate the myopiod receptors in the smooth muscle of the gut.

This causes a sustained non -propulsive contraction.

It basically freezes the gut muscle, stopping the rhythmic peristalsis that pushes things along.

So it gives the intestines more time to absorb water back out of the stool.

And lupuramide is safe to buy over the counter because it doesn't really get into the brain, right?

Right.

It's highly selective for gut receptors and is actively pumped out of the brain if it does get in.

Diphenoxalate is similar, but there is a catch.

At very high doses, it can have some CNS effects.

So how do they prevent people from abusing it?

They combine it with a tiny amount of atropine.

Atropine, which causes unpleasant side effects like dry mouth and blurred vision.

Exactly.

They put it in there as an abuse deterrent.

If you take too much diphenoxalate to try and get high,

the atropine makes you feel so lousy that you won't want to do it again.

What about traveler's diarrhea?

That's usually an infection.

Yes, usually from bacteria, often E.

coli.

For that, rifaximin is the drug of choice mentioned in the text.

It's an antibiotic that works by binding to bacterial RNA polymerase.

And what's special about it?

The cool thing is that it is very poorly absorbed from the gut.

So it stays in the intestines and kills the bad bugs locally without having much systemic effect on the rest of the body.

There's a drug here called crofilamer with a very, very specific indication.

Yes, this is for HIV AIDS patients who are on antiretroviral therapy and have persistent non -infectious diarrhea.

And the mechanism.

It blocks two types of chloride channels in the gut.

The CFTR channel and the calcium activated chloride channels.

It directly stops the mechanism of water secretion into the gut.

Lastly, for diarrhea, we have the drugs for IBS with diarrhea or IBSD elastron.

This one has a bit of a scary history.

It does.

Elastron is a 5 -HT3 receptor antagonist.

It blocks serotonin on the vagal nerves coming from the gut, which reduces pain, nausea, and slows everything down.

But it's highly restricted.

How so?

It's only approved for women with severe IBSD who have failed all other treatments.

And why such a tight restriction?

A rare but very serious side effect, ischemic colitis.

It can slow motility and constrict blood vessels so much that it cuts off blood flow to the colon, causing the tissue to die.

Because of that risk, it's regulated under a very strict risk management program.

That brings us to our final, and maybe most complex, section.

Section 6.

The anti -medics.

Or as I like to call it, please don't throw up on me.

Nausea and vomiting.

It's one of the most complex coordinated reflexes in the human body.

The text provides this diagram, figure 28 .3, and it honestly looks like a schematic for a nuclear power plant.

It's not just one button.

There are inputs coming from all over the place.

That is the absolute key to learning the drugs.

You can't just memorize a list of anti -vomit drugs.

You have to ask, where is the signal coming from?

Because the Vomiting Center in the medulla, it's just the coordinator.

It's the CPU, it's the general.

But it relies on its field sensors to tell it when to trigger the heave.

Let's break down those sensors.

The text lists four main inputs.

First, the camera receptor trigger zone, or CTZ.

This is a really cool piece of anatomy.

It's located in a part of the brainstem called the area post -drama.

What makes it so special is that it is outside the blood -brain barrier.

Wait, parts of the brain can be outside the barrier?

Just this little part.

It acts like a chemical sampling station for the body.

It constantly tastes the blood and the cerebrospinal fluid.

It's looking for toxins, for drugs, for metabolic waste products.

So if it detects a poison in the blood?

It screams at the Vomiting Center.

We are poisoned.

Evacuate the stomach immediately.

So that's why chemotherapy causes such profound vomiting.

The chemo drugs are in the blood and the CTZ tastes them.

Exactly.

And the CTZ is loaded with very specific types of receptors,

mainly dopamine D2 and serotonin 5 -HT3.

Okay, hold that thought.

Second input, the vestibular apparatus.

Your inner ear, balance, motion.

If you're on a boat and the horizon is bobbing up and down, your inner ear sends a mismatched signal to the brain.

This travels via the cerebellum to the Vomiting Center.

But here, the receptors involved are different.

What are they?

It's mostly muscarinic and histamine H1 receptors.

This is a crucial distinction.

So if I'm seasick, my CTZ is perfectly fine.

It's my inner ear that's unhappy.

Right.

Which is why taking on Dancitron, a serotonin blocker, doesn't do much for seasickness.

You're blocking the wrong receptor.

You need a histamine blocker or a muscarinic blocker to treat motion sickness.

So knowing the source of the nausea dictates the cure?

100%.

We also have inputs directly from the GI tract itself.

If you eat something rotten, the stomach lining gets irritated and releases serotonin, which travels up the vagus nerve to the brain.

And finally, you have inputs from the cerebral cortex, anxiety, fear, or even just seeing or smelling something disgusting.

So now that we have the MAP CTZ vestibular GI cortex, we can overlay the drugs.

Let's start with the heavy hitters for chemotherapy -induced nausea, the cetrons.

The 5 -HT3 antagonists on Dancitron, Granistron, Pelinocetron.

These drugs absolutely revolutionized cancer care.

Before they existed, chemo regimens with drugs like high -dose cisplatin were almost intolerable because of the severe vomiting.

And how do they work, exactly?

They're snipers.

They specifically target and block the 5 -HT3 receptors.

And remember where we said those were concentrated?

In the CTZ and on the vagal nerve endings coming from the gut.

Precisely.

So by blocking them, you silence the poison alarm that's coming from both the blood and the gut.

The text calls them the gold standard, but even gold has its scratches.

Is there a safety warning with these?

Generally, they are very safe.

The most common side effects are headache and constipation.

But there is a specific warning for one of them, delastron.

Dolastron.

High doses,

especially when given intravenously, can prolong the QT interval on an EKG.

Which is a delay in the electrical recharging of the heart.

Correct.

And that can, in rare cases, lead to a fatal arrhythmia called torsade de pointe.

Because of that risk, high IV doses are now generally avoided.

Okay.

Then we have the neurokinin -1 or NK1 antagonists.

A prepatent is the example.

This targets a different pathway entirely.

It blocks a neurotransmitter called substance P from binding to his NK1 receptors in the brainstem, specifically in a place called the solitary tract nucleus.

And when do we use these?

They are particularly good for the delayed phase of chemo -induced vomiting.

The vomiting that happens, you know, a day or two later.

You often see them used in a three -drug combination for highly -amidogenic chemo.

That's the combo.

A 5 -HT3 blocker, like on Ancetron, plus an NK1 blocker, like a prepatent, plus dexamethasone.

Dexamethasone is a steroid.

Why does a steroid help with vomiting?

The text admits the exact mechanism isn't fully understood, but it works synergistically with the other drugs to powerfully suppress inflammation and the entire emetic response.

We also have the dopamine D2 antagonists for nausea.

We've seen some of these before.

Yes, metoclopramide again.

And also the classic anti -psychotic drugs like prochlorperazine and promethazine.

They work by blocking D2 receptors in the CTZ.

Promethazine is a really common one, but it makes you so sleepy.

Very sleepy.

That's because it's what we call a dirty drug.

It's not very selective.

It blocks dopamine receptors, but it also strongly blocks histamine H1 and muscarinic receptors.

That sedation can sometimes be useful, but it can also be a real hindrance.

Now, here's a fascinating paradox.

Cannabinoids.

Marijuana derivatives.

Tronabinol.

This is synthetic THC.

It stimulates CB1 receptors in and around the vomiting center.

It's typically used for chemoemesis when other things fail.

And also, importantly, to stimulate appetite in AIDS patients.

But the text mentions a condition called cannabinoid hyperemesis syndrome.

Yes.

This is a very strange and increasingly recognized phenomenon.

Chronic, heavy, daily users of cannabis can develop these severe cyclical episodes of intractable vomiting.

So the thing that's supposed to stop vomiting is causing it.

Exactly.

The text notes this very curious feature where taking hot showers or baths provides temporary relief, but the only actual cure is to stop using cannabis completely.

It's a very strange paradoxical effect.

Motion sickness, you said, is its own beast.

It is because it involves the vestibular system.

So we use drugs that target those pathways.

Scopolamine is the classic, one muscarinic antagonist.

It often comes as a patch you put behind your ear before cruiser a flight.

Or antihistamines like diamond hydrogenate or meclizine.

Exactly.

They block both H1 and M1 receptors, which are key for the vestibular inputs.

But again, remember, they cause sedation.

Don't plan on driving.

And finally, a very sensitive topic.

Pregnancy.

Morning sickness.

We have to be incredibly careful here with drug selection.

The first line choice, recommended in the text, is a combination product called Decligeus.

And what's in that?

It's a combination of doxylamine, which is an antihistamine, plus vitamin B6 or pyridoxin.

It has the best and longest safety profile for use in pregnancy.

Wow.

We have traversed the entire GI tract from top to bottom.

From the acid pump in the stomach all the way to the complex nerve centers in the medulla.

So if we had to sum this whole chapter up for the listener who is, driving to their exam right now, what are the absolute must -knows?

I'd say remember the big three strategies.

First, inhibit acid.

Okay.

Use PPIs to kill the pump irreversibly for profound suppression, or use H2 blockers to just stop the signal.

And always, always, if there's an ulcer, don't forget to treat H.

pylori.

Second big strategy.

Modulate motility.

Use a prokinetic like metaclopramide to speed things up, but you have to watch out for those Parkinson -like side effects.

Or use laxatives and opioids to manage the speed in either direction.

And third.

Block receptors for vomiting.

Yeah.

But don't just guess.

You have to know the trigger.

If it's chemo or something in the gut, block serotonin with a 5 -HT3 antagonist.

If it's motion sickness, block histamine or muscarinic receptors.

You have to match the drug to the receptor that's firing.

And never forget, smetadyne blocks P450 enzymes.

A classic exam question.

Mesoprospel is contraindicated in pregnancy because it causes labor.

Absolutely critical.

And always check for H.

pylori in a patient with PUD.

Those are essential takeaways.

This chapter really highlights how pharmacology isn't just about this drug treats that disease.

It's so much more about the mechanism.

Is it a receptor?

Is it a pump?

Is it inflammation?

Is it a neurotransmitter?

Exactly.

When you understand the underlying physiology, like that diagram of the parietal cell we talked about, or the inputs to the vomiting center, the drugs just make logical sense.

You aren't just memorizing a list of names.

You are learning how to manipulate the system.

And that is the best way to learn and the safest way to practice.

Thank you so much for diving deep with us today.

Always a pleasure.

To our listener, good luck with the exam, good luck on your rounds, or, you know, just good luck managing your own digestion.

From all of us on the Last Minute Lecture Team, thanks for listening.

Take care.